AIThe Decoder2h ago
OpenAI acquires Orchestra Bio to build AI agents
OpenAI acquires Orchestra Bio to build AI agents that speed up drug development
OpenAI is acquiring startup Orchestra Bio and plans to merge it with its life sciences AI platform Rosalind. The goal is to build AI agents that help pharma teams coordinate drug development, from tracking trials to spotting problems. Developing a new drug in the US takes ten to…
Read full articleSource: The Decoder · Opens in new tab